Home688136 • SHA
add
Kexing Biopharm Co Ltd
Previous close
¥36.18
Day range
¥37.00 - ¥42.05
Year range
¥13.67 - ¥42.10
Market cap
7.22B CNY
Avg Volume
5.17M
P/E ratio
187.57
Dividend yield
-
Primary exchange
SHA
Market news
Financials
Income Statement
Revenue
Net income
| (CNY) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | 353.56M | -1.97% |
Operating expense | 202.00M | -15.12% |
Net income | 25.58M | 106.21% |
Net profit margin | 7.23 | 110.17% |
Earnings per share | — | — |
EBITDA | 59.50M | 40.77% |
Effective tax rate | 21.82% | — |
Balance Sheet
Total assets
Total liabilities
| (CNY) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 576.27M | 6.27% |
Total assets | 3.19B | 4.24% |
Total liabilities | 1.53B | 5.96% |
Total equity | 1.67B | — |
Shares outstanding | 197.76M | — |
Price to book | 4.30 | — |
Return on assets | 2.99% | — |
Return on capital | 3.29% | — |
Cash Flow
Net change in cash
| (CNY) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | 25.58M | 106.21% |
Cash from operations | 25.45M | 508.80% |
Cash from investing | -110.34M | 50.76% |
Cash from financing | 20.66M | 24.58% |
Net change in cash | -63.78M | 70.07% |
Free cash flow | -32.21M | 73.50% |
About
Founded
1989
Website
Employees
947
